A Peroxisome Proliferator-Activated Receptor-&ggr; Agonist Reduces Infarct Size in Transient but Not in Permanent Ischemia

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Stroke

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000152271.21943.a2PMID 15618443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke

  2003cited by this paper
• PPAR&ggr; Inhibition of Cyclooxygenase-2, PGE2 Synthase, and Inducible Nitric Oxide Synthase in Cardiac Myocytes

  2003cited by this paper
• Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice

  2003cited by this paper
• Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.

  2003cited by this paper
• Copper Modulates the Degradation of Copper Chaperone for Cu,Zn Superoxide Dismutase by the 26 S Proteosome*

  2003cited by this paper
• Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease

  2002cited by this paper
• Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons.

  2002cited by this paper
• Anti-Inflammatory Mechanisms in the Vascular Wall

  2001cited by this paper
• The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.

  2001cited by this paper
• The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

  2001cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo

  2000cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.

  2000cited by this paper
• Medical significance of peroxisome proliferator-activated receptors.

  1999cited by this paper
• Distribution of mRNAs Encoding the Peroxisome Proliferator‐Activated Receptor α, β, and γ and the Retinoid X Receptor α, β, and γ in Rat Central Nervous System

  1998cited by this paper
• Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system.

  1998cited by this paper
• Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.

  1997cited by this paper
• Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng.

  1996cited by this paper
• Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat.

  1995cited by this paper
• An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat.

  1994cited by this paper
• Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia.

  1993cited by this paper
• Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase.

  1991cited by this paper
• Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats.

  1989cited by this paper
• Experimental studies of ischemic brain edema

  1986cited by this paper

• Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague–Dawley Rats: Targeting HMGB-1/NF-κB Pathway

  2025cites this paper
• Electroacupuncture alleviates motor dysfunction after intracerebral hemorrhage via the PPARγ-EAAT2 pathway

  2025cites this paper
• Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice.

  2023cites this paper
• PPARγ Regulates Macrophage Polarization by Inhibiting the JAK/STAT Pathway and Attenuates Myocardial Ischemia/Reperfusion Injury In Vivo

  2023cites this paper
• Novel mechanistic insight on the neuroprotective effect of berberine: The role of PPARδ for antioxidant action.

  2022cites this paper
• Beneficial effects of neuronal ATF6 activation in permanent ischemic stroke

  2022cites this paper
• Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic Diseases

  2021cites this paper
• PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage

  2021influential citation
• PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy

  2021cites this paper
• Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice

  2021cites this paper
• Inhibiting ferroptosis: a novel approach for stroke therapeutics.

  2021cites this paper
• Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury

  2021cites this paper
• Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis

  2021cites this paper
• Relationship between PPAR‐γ gene polymorphisms and ischemic stroke risk: A meta‐analysis

  2021cites this paper
• Brain‑derived neurotrophic factor and nitric oxide contribute to protective effects of rosiglitazone on learning and memory in hypothyroid rats.

  2021cites this paper
• Nitro-oleic acid-mediated blood-brain barrier protection reduces ischemic brain injury.

  2021cites this paper
• Role of peroxisome proliferator‐activated receptors in stroke prevention and therapy—The best is yet to come?

  2020cites this paper
• Animal models of cerebral ischemia: A review.

  2020cites this paper
• The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury

  2020cites this paper
• Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke

  2019cites this paper
• 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface

  2019cites this paper
• Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice

  2019cites this paper
• Effects of PPAR-γ agonist, pioglitazone on brain tissues oxidative damage and learning and memory impairment in juvenile hypothyroid rats

  2019cites this paper
• Neurovascular Network as Future Therapeutic Targets

  2018cites this paper
• Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure

  2018cites this paper
• Diverse roles of mitochondria in ischemic stroke

  2018cites this paper
• Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation

  2018cites this paper
• Serum PPARγ level and PPARγ gene polymorphism as well as severity and prognosis of brain injury in patients with arteriosclotic cerebral infarction

  2018cites this paper
• Association Between PPARs Gene Functional Polymorphisms and Ischemic Stroke in Chinese Uyghur Population

  2018cites this paper
• Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-ɤ

  2018cites this paper
• Animal Models for Ischemic Stroke

  2017cites this paper
• Anti-heat Shock 70 kDa Protein Antibody Induced Neuronal Cell Death.

  2017cites this paper
• Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases

  2017cites this paper
• Effects of PPARγ agonist decreasing the IL-1β, IL-6 and TNF-α content in rats on focal cerebral ischemia-reperfusion injury

  2017cites this paper
• Effect of Clofibrate, A PPAR-Α Receptors Agonist, On Behavioral Despair Associated With Exposure to Forced Swim in Rats

  2017cites this paper
• Technology Open Access book

  2017cites this paper
• Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke

  2017cites this paper
• Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation

  2017cites this paper
• Peroxisome proliferator-activated receptor-gamma dependent pathway reduces the phosphorylation of dynamin-related protein 1 and ameliorates hippocampal injury induced by global ischemia in rats

  2016cites this paper
• Long-term survival in permanent middle cerebral artery occlusion: a model of malignant stroke in rats

  2016cites this paper
• Is the cardiovascular system a therapeutic target for CBD ?

  2016cites this paper
• The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial

  2016cites this paper
• Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats

  2016cites this paper
• Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosis.

  2015cites this paper
• Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2

  2015cites this paper
• Pleiotropic Role of PPARγ in Intracerebral Hemorrhage: An Intricate System Involving Nrf2, RXR, and NF‐κB

  2015cites this paper
• Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.

  2015cites this paper
• Neuroprotection by Dietary Isoflavones and Their Role in Cerebral Ischemia

  2015cites this paper
• Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.

  2015cites this paper
• A single dose of PPARγ agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats.

  2015cites this paper
• Pioglitazone Enhances Survival and Regeneration of Pelvic Ganglion Neurons After Cavernosal Nerve Injury.

  2015cites this paper
• Effects of pharmacological and surgical interventions on ischemia reperfusion injury in bilateral acute hind limb ischemia rat model

  2015cites this paper
• Neuroprotective effects of pioglitazone against transient cerebral ischemic reperfusion injury in diabetic rats: Modulation of antioxidant, anti-inflammatory, and anti-apoptotic biomarkers

  2015cites this paper
• Gastrodin Alleviates Cerebral Ischemic Damage in Mice by Improving Anti-oxidant and Anti-inflammation Activities and Inhibiting Apoptosis Pathway

  2015cites this paper
• Identification of astrocytic factors that could play a role in myelination

  2015cites this paper
• Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation.

  2015cites this paper
• PPAR-γ Ameliorates Neuronal Apoptosis and Ischemic Brain Injury via Suppressing NF-κB-Driven p22phox Transcription

  2015cites this paper
• A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPARγ agonists.

  2015cites this paper
• Rosiglitazone Increases Cerebral Klotho Expression to Reverse Baroreflex in Type 1-Like Diabetic Rats

  2014cites this paper
• Pharmacological applications of antioxidants: lights and shadows.

  2014cites this paper
• The Role of PPARγ in Stroke

  2014cites this paper
• Ligand-activated PPAR- γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 ε upregulation

  2014cites this paper
• Rosiglitazone‐induced CD36 up‐regulation resolves inflammation by PPARγ and 5‐LO‐dependent pathways

  2014cites this paper
• The peroxisome proliferator‐activated receptor‐γ agonist pioglitazone protects against cisplatin‐induced renal damage in mice

  2014cites this paper
• PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.

  2014cites this paper
• Link Between Oxidative Stress and Acute Brain Ischemia

  2014cites this paper
• Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity

  2014cites this paper
• PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status

  2014cites this paper
• Beneficial effects of maternal dietary omega-3 fatty acids on placental growth and fuction

  2014cites this paper
• Identification of novel scaffolds for Monoamine oxidase B inhibitors

  2014cites this paper
• Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats

  2014cites this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonist 15d-Prostaglandin J2 Mediates Neuronal Autophagy after Cerebral Ischemia-Reperfusion Injury

  2013cites this paper
• Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke

  2013cites this paper
• Design of a Prospective, Dose-Escalation Study Evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)

  2013cites this paper
• Prevention of JNK Phosphorylation as a Mechanism for Rosiglitazone in Neuroprotection after Transient Cerebral Ischemia: Activation of Dual Specificity Phosphatase

  2013cites this paper
• Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity.

  2013cites this paper
• PPARs: a potential target for a disease-modifying strategy in stroke.

  2013cites this paper
• Dragon's blood dropping pills have protective effects on focal cerebral ischemia rats model.

  2013cites this paper
• Is the cardiovascular system a therapeutic target for cannabidiol?

  2013cites this paper
• PPAR-γ Agonist GW1929 But Not Antagonist GW9662 Reduces TBBPA-Induced Neurotoxicity in Primary Neocortical Cells

  2013cites this paper
• Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain

  2013cites this paper
• NADPH oxidases as therapeutic targets in ischemic stroke

  2012cites this paper
• PPAR Agonism as New Pharmacological Approach to the Management of Acute Ischemic Stroke

  2012cites this paper
• Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation.

  2012cites this paper
• Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention.

  2012cites this paper
• Low-Dose Alcohol Consumption Protects against Transient Focal Cerebral Ischemia in Mice: Possible Role of PPARγ

  2012cites this paper
• Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats.

  2012cites this paper
• New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury

  2012cites this paper
• Neuroprotection by dietary restriction and the PPAR transcription complex

  2012cites this paper
• Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.

  2012cites this paper
• The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat.

  2012cites this paper
• Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway

  2012cites this paper
• The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function

  2012cites this paper
• Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma.

  2012cites this paper
• Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice.

  2012cites this paper
• Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.

  2012cites this paper
• Flurbiprofen axetil promotes neuroprotection by activation of cerebral peroxisome proliferator-activated receptor gamma after focal cerebral ischemia in rats.

  2012cites this paper
• Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice.

  2012cites this paper
• Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats

  2012cites this paper
• Hyperglycemia Induces the Variations of 11β-Hydroxysteroid Dehydrogenase Type 1 and Peroxisome Proliferator-Activated Receptor-γ Expression in Hippocampus and Hypothalamus of Diabetic Rats

  2012cites this paper